Krystal Biotech Inc
Krystal Biotech Inc (KRYS) Unusual Options Activity Today
KRYS options volume power reached 1.64x on the previous trading day. The highest reading was on the $380 CALL expiring 2026-10-16.
Read more
Checking KRYS unusual options activity helps you spot when traders are making outsized bets on Krystal Biotech Inc before the broader market catches on. Krystal Biotech Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor KRYS unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching KRYS unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking KRYS unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and KRYS unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome.
Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.
Catalysts rarely arrive without a footprint, and KRYS unusual options activity is often where that footprint shows up first. Our scanner tracks Krystal Biotech Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at KRYS unusual options volume on the call side or chasing put sweeps, Krystal Biotech Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 380.00 | 1.75 | 5.00 | 3.38 | 41% | 23 | 14 | 164.29% |
| 340.00 | 15.50 | 18.40 | 16.95 | 41% | 3 | 5 | 60.00% |
| 350.00 | 9.40 | 13.00 | 11.20 | 39% | 7 | 29 | 24.14% |
| 370.00 | 2.40 | 5.80 | 4.10 | 37% | 3 | 13 | 23.08% |
| 400.00 | 0.05 | 2.45 | 1.25 | 42% | 12 | 64 | 18.75% |
| 350.00 | 12.10 | 16.00 | 14.05 | 37% | 4 | 3 | 133.33% |
| 340.00 | 7.10 | 11.40 | 9.25 | 38% | 8 | 167 | 4.79% |
| 320.00 | 1.30 | 5.50 | 3.40 | 39% | 6 | 198 | 3.03% |
| 195.00 | — | 5.00 | 5.00 | 184% | 0 | 0 | — |
| 200.00 | — | 5.00 | 5.00 | 178% | 0 | 1 | 0.00% |
As of September 28, 2026
Spot unusual options activity before it moves
Track KRYS options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→